BGI Genomics breaks new ground in Saudi Arabian precision medicine

Dr. Louis Luo introduces potential large-scale applications of precision medicine at the Saudi Society of Medical Genetics Annual Conference

2023-10-04

(Press-News.org) The Saudi Society of Medical Genetics Annual Conference 2023 was held in Riyadh, Saudi Arabia, on September 29-30, 2023. As the most authoritative academic conference on precision medicine in the Kingdom, this conference attracted global experts worldwide.

One of the highlights of the conference was the presentation entitled "Spatial-temporal sequencing and some large-scale application of precision medicine technologies," delivered by Dr. Louis (Renyuan) Luo, VP of BGI Genomics West Asia, at the invitation of the Saudi Society of Medical Genetics.

Dr. Luo's presentation discussed the importance of spatiotemporal sequencing technology in the field of precision medicine and its potential large-scale applications, introduced the company's case studies, such as the world's first multi-center project of newborn genetic screening, large-scale regional noninvasive prenatal testing (NIPT) coverage and extensive early screening project of colorectal cancer at Wuhan, Hubei province, China.

Besides sharing BGI Genomics research achievements and innovative applications in enhancing medical outcomes, Dr. Luo highlighted Genalive, BGI Genomics joint venture laboratory in the Kingdom of Saudi Arabia. This is the result of a localized strategic partnership aiming to provide cutting-edge precision medicine services, promote development and contribute to improving the country's healthcare system.

The success of Dr. Luo's presentation paves the way for deepening future localized collaboration and innovation in Saudi Arabia. BGI Genomics will continue to support the realization of Saudi Vision 2030 through active participation in global cooperation and exchanges in the field of precision medicine to enhance patients' health outcomes.

About BGI Genomics:

BGI Genomics, headquartered in Shenzhen, China, is the world's leading integrated solutions provider of precision medicine. Our services cover more than 100 countries and regions, involving more than 2,300 medical institutions. In July 2017, as a subsidiary of BGI Group, BGI Genomics (300676.SZ) was officially listed on the Shenzhen Stock Exchange.

END

[Attachments] See images for this press release:

BGI Genomics breaks new ground in Saudi Arabian precision medicine 2

BGI Genomics breaks new ground in Saudi Arabian precision medicine 3

ELSE PRESS RELEASES FROM THIS DATE:

Portable laboratory devices can detect SARS-CoV-2

2023-10-04

Washington, D.C. — A new study has demonstrated rapid and sensitive on-site detection of SARS-CoV-2 RNA from environmental surfaces using a portable laboratory device. The study was published in Microbiology Spectrum, a journal of the American Society for Microbiology. “Our findings hold promising implications for scenarios where access to testing laboratories is challenging, such as in cruise ships, international travel, remote islands and tourist destinations,” said lead study author Kouichi Kitamura, Ph.D., National Institute of Infectious ...

Challenges in acute heart attack care continue post COVID-19

2023-10-04

A door-to-balloon (D2B) time of 90-minutes or less is associated with improved outcomes for heart attack patients. However, during the COVID-19 pandemic certain obstacles—including the need for COVID-19 screening, associated isolation procedures and terminal cleaning in the cardiac cath lab—led to increased D2B times. According to a new study, presented at the American College of Cardiology (ACC) Quality Summit 2023, many health care facilities are still recovering from the pandemic and facing new challenges, causing D2B times to continue to lag. A myocardial infarction, or heart attack, occurs when there has been a blockage ...

Researchers design potential therapy to prevent brain deterioration in children with rare genetic conditions

2023-10-04

Francis Crick Institute press release Under strict embargo: 14:00 BST / 09:00hrs ET Wednesday 4 October 2023 Peer reviewed Observational and experimental studies People and cells A research team at the Francis Crick Institute and Great Ormond Street Hospital (GOSH)/UCL Great Ormond Street Institute of Child Health have identified new potential treatments for children with rare genetic conditions of blood vessels, which cause severe, lifelong, and disabling symptoms like seizures and impaired development. Through two papers published today in the Journal of Investigative ...

Reactivate, repurpose, and rewire the brain

2023-10-04

Developing brains become shaped by the sights, sounds, and experiences of early life. The brain’s circuits grow more stable as we age. However, some experiences later in life open up opportunities for these circuits to be rapidly rewired. New research from Cold Spring Harbor Laboratory Associate Professor Stephen Shea helps explain how the brain adapts during a critical period of adulthood: the time when new mothers learn to care for their young. Shea’s work in mice shows how this learning process ...

American Society for Metabolic and Bariatric Surgery names new executive director after yearlong search

2023-10-04

After a yearlong and extensive nationwide search, the American Society for Metabolic and Bariatric Surgery (ASMBS), the nation’s largest professional organization of bariatric and metabolic surgeons and integrated health professionals, has named healthcare association veteran Diane M. Enos MPH, RDN, CAE, FAND, to serve as its new executive director. Before joining ASMBS, Enos, a registered dietitian and certified association executive with a master’s degree in public health from the University of Texas Health Science Center in Houston, was Chief Learning Officer of the Academy of Nutrition and Dietetics, ...

Antibody therapy inspired by patient case reduced tau tangles in a preclinical model of Alzheimer’s disease

2023-10-04

A team led by researchers from Mass General Brigham reports promising results for a monoclonal antibody that takes aim at a new target for Alzheimer’s disease. Inspired by their previous identification of a genetic variant in the APOE gene that provides extreme resistance against Alzheimer’s disease, the team, which includes investigators from Mass Eye and Ear and Massachusetts General Hospital, developed a therapy that mimics the behavior of this genetic variant in a preclinical model, reducing ...

Demystifying the role of plant x- and y-type thioredoxins

2023-10-04

The potential for exposure to fluctuating light has necessitated that plants evolve protective mechanisms for when the light intensity exceeds photosynthetic capacity. Under these conditions, reactive oxygen species cause photoinhibition, which hinders photosynthetic efficiency. To counter this loss in photosynthetic efficiency, chloroplasts evolved thioredoxin (Trx) proteins that regulate redox balance within the photosynthetic apparatus and provide a photoprotective function. These proteins allow plants to modulate photosynthesis in response to variations in light intensity. ...

Graphene oxide reduces the toxicity of Alzheimer’s proteins

2023-10-04

A probable early driver of Alzheimer's disease is the accumulation of molecules called amyloid peptides. These cause cell death, and are commonly found in the brains of Alzheimer’s patients. Researchers at Chalmers University of Technology, Sweden, have now shown that yeast cells that accumulate these misfolded amyloid peptides can recover after being treated with graphene oxide nanoflakes. Alzheimer’s disease is an incurable brain disease, leading to dementia and death, that causes suffering for both the patients and their ...

Avatars to help tailor glioblastoma therapies

2023-10-04

Scientists have created a new zebrafish xenograft platform to screen for novel treatments for an aggressive brain tumor called glioblastoma, according to a new study by the Gerhardt and De Smet labs published in EMBO Molecular Medicine. Joint press release – Max Delbrück Center, VIB, and KU Leuven Glioblastoma is an aggressive and difficult-to-treat brain tumor in adults. On average, patients survive for only 1.5 years. The standard of care treatment for this disease, which includes surgery followed by radiation and chemotherapy, has not changed in 18 years. That’s partly because the cancer is ...

Oxford researchers develop 3D printing method that shows promise for repairing brain injuries

2023-10-04

Researchers have produced an engineered tissue representing a simplified cerebral cortex by 3D printing human stem cells. When implanted into mouse brain slices, the structures became integrated with the host tissue. The technique may ultimately be developed into tailored repairs to treat brain injuries. A breakthrough technique developed by University of Oxford researchers could one day provide tailored repairs for those who suffer brain injuries. The researchers demonstrated for the first time that neural cells can be 3D printed to mimic the architecture of the cerebral cortex. The results have been published today in the ...

LAST 30 PRESS RELEASES:

Exploring the link between hearing loss and cognitive decline

Machine learning tool can predict serious transplant complications months earlier

Prevalence of over-the-counter and prescription medication use in the US

US child mental health care need, unmet needs, and difficulty accessing services

Incidental rotator cuff abnormalities on magnetic resonance imaging

Sensing local fibers in pancreatic tumors, cancer cells ‘choose’ to either grow or tolerate treatment

Barriers to mental health care leave many children behind, new data cautions

Cancer and inflammation: immunologic interplay, translational advances, and clinical strategies

Bioactive polyphenolic compounds and in vitro anti-degenerative property-based pharmacological propensities of some promising germplasms of Amaranthus hypochondriacus L.